Leerink Partners Raises Price Target on Globus Medical (GMED) Following 2Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Globus Medical Reports Second Quarter 2015 Results
July 30, 2015 4:15 PM EDTReports Record Quarterly Sales and Increases Guidance
AUDUBON, Pa.--(BUSINESS WIRE)-- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2015.
Worldwide sales increased 17.6% to $133.6 million, or 19.1% on a constant currency basis Second quarter net income increased 16.5% to $24.1 million... More